← FDA DRUG APPROVALS

FDA ANDA · ANDA073458

CLEMASTINE FUMARATE

Sponsor: PLD ACQUISITIONS LLC

APPLICATION
ANDA073458
TYPE
ANDA
ORIGINAL APPROVAL
1993-10-31
LATEST ACTION
2002-12-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLEMASTINE FUMARATEDiscontinued
CLEMASTINE FUMARATE 1.34MG · TABLET · ORAL

Approval history

2002-12-16Manufacturing (CMC) · Supplement 11AP
2002-05-15Manufacturing (CMC) · Supplement 10AP
2002-04-15Manufacturing (CMC) · Supplement 9AP
2001-08-07Manufacturing (CMC) · Supplement 8AP
2001-01-02Manufacturing (CMC) · Supplement 7AP
2001-01-02Manufacturing (CMC) · Supplement 6AP
2000-11-30Manufacturing (CMC) · Supplement 5AP
1999-05-05Manufacturing (CMC) · Supplement 3AP
1998-03-27Manufacturing (CMC) · Supplement 2AP
1997-08-15Manufacturing (CMC) · Supplement 1AP
1993-10-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →